Peripheral blood microchimerism in human liver and renal transplant recipients: Rejection despite donor-specific chimerism

Transplantation

Volumn 64, Issue 3, 1997, Pages 427-432

  Sivasai, Krovvidi S R ^a   Alevy, Yael G ^a   Duffy, Brian F ^a   Brennan, Daniel C ^a   Singer, Gary G ^a   Shenoy, Surendra ^a   Lowell, Jeffrey A ^a   Howard, Todd ^a   Mohanakumar, T ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CHIMERA; CLINICAL ARTICLE; DONOR; GRAFT REJECTION; HISTOINCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ALLELES; BLOOD TRANSFUSION; BLOTTING, SOUTHERN; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; REOPERATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030804037     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199708150-00010     Document Type: Article

References (39)

1. Starzl T, Trucco M, Zeevi A, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
2. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
3. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
4. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577.
5. Flye MW, Burton K, Mohanakumar T, et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395.
6. Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997; 63: 7.
7. Singal DP, Ludwin D, Blajchman MA. Blood transfusion and renal transplantation. Br J Haematol 1985; 61: 595.
8. Monaco AP, Clark AW, Brown RW. Active enhancement of a human cadaver renal allograft with ALS and donor bone marrow: case report of an initial attempt. Surgery 1976; 79: 384.
9. DeWaal LP, vanTwuyer E. Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation? Crit Rev Immunol 1991; 10: 417.
10. Opelz G, Sentar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
11. Bradley JA. The blood transfusion effect: experimental aspects. Immunol Lett 1991; 29: 127.
12. Wood PJ, Roberts ISD, Yang C, Cossens IA, Bell EB. Prevention of chronic rejection by donor-specific blood transfusion in a new model of chronic cardiac allograft rejection. Transplantation 1996; 61: 1440.
13. Adams PT, Davenport RD, Reardon DA, Roth MS. Detection of circulating donor white blood cells in patients receiving multiple transfusions. Blood 1992; 80: 551.
14. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
15. McDaniel DO, Naftilan J, Hulvey K, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 1994; 57: 852.
16. Dzik WH. Mononuclear cell microchimerism and the immunomodulatory effect of transfusion. Transfusion 1994; 34: 1007.
17. Suberbielle C, Calliat-Zucman S, Legendre C. Peripheral microchimerism in long term cadaveric kidney allograft recipients. Lancet 1994; 343: 1468.
18. Caillat-Zucman S, Logendre C, Suberbielle C, et al. Microchimerism frequency 2 to 20 years after cadaveric kidney transplantation. Hum Immunol 1994; 41: 91.
19. Ishida H, Kawai T, Tanabe K. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation 1996; 62: 126.
20. Hundrieser J, Hisanaga M, Boker K, et al. Long-term chimerism in liver transplantation: no evidence for immunological relevance but requirement for graft persistence. Transplant Proc 1995; 27: 216.
21. Schlitt HJ, Hundrieser J, Hisanaga M. Patterns of donor type microchimerism after heart transplantation. Lancet 1994; 343: 1469.
22. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. New Engl J Med 1994; 330: 646.
23. Molleston JP, Alevy YG, SivaSai KSR, Mohanakumar T, Howard TK. Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. Transplantation 1996; 61: 656.
24. Brennan DC, Mohanakumar T, Flye MW. Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms. Am J Kidney Dis 1995; 26: 701.
25. Kawasaki ES. Sample preparation from blood, cells and other fluids. In: Innis MA, Gelfand FH, Sninsky JJ, White TJ, eds. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, Inc., 1990: 146.
26. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503.
27. Gilliand G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive PCR. Proc Natl Acad Sci USA 1990; 87: 2725.
28. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
29. Maeda T, Eto M, Nishimura Y, Nomoto K, Kong YY. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice. J Immunol 1993; 150: 753.
30. Murase N, Starzl TE, Tanabe M, et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 1995; 60: 158.
31. Shirwan H, Wang HK, Barwari L, Makowka L, Cramer DV. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation 1996; 61: 1382.
32. Smith JP, Kasten-Jolly J, Field LJ, Thomas JM. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice. Transplantation 1994; 58: 324.
33. Alard P, Matriano JA, Socarras S, Ortega MA, Streitlein JW. Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice: microchimerism fails to predict tolerance. Transplantation 1995; 60: 1125.
34. Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts. Transplant Proc 1995; 27: 151.
35. Goto S, Kamada N, Lord R, Kobayashi E, Enosawa S, Kim YI. Induction of natural chimerism after retransplantation of the liver in rats. Transplantation 1994; 58: 1230.
36. Restifo NP, Esquivel F, Asher AL, et al. Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor immune response. J Immunol 1991; 147: 1453.
37. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
38. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539.
39. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.